Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.

Autor: Alhamar M; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Tudor Vladislav I; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Smith SC; Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA., Gao Y; Department of Pathology, Memorial University, St John's, Newfoundland, Canada., Cheng L; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Favazza LA; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Alani AM; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA., Ittmann MM; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA., Riddle ND; Department of Pathology, USF Health, Ruffolo, Hooper, and Associates, Tampa, FL, USA., Whiteley LJ; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Gupta NS; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Carskadon S; Department of Urology, Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI, USA., Gomez-Gelvez JC; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Chitale DA; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.; Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA., Palanisamy N; Department of Urology, Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI, USA., Hes O; Department of Pathology, Charles University Faculty of Medicine, Plzen, Czech Republic., Trpkov K; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Williamson SR; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.; Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.

Publikováno v: Histopathology [Histopathology] 2020 Dec; Vol. 77 (6), pp. 890-899. Date of Electronic Publication: 2020 Sep 13.

Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Autor: Lehman NL; Department of Pathology and Laboratory Medicine, The Hermelin Brain Tumor Center, Henry Ford Hospital, and Department of Pathology, Wayne State University, Detroit, MI, USA. nllehman@yahoo.com, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM

Publikováno v: Cell cycle (Georgetown, Tex.) [Cell Cycle] 2012 Feb 01; Vol. 11 (3), pp. 489-502. Date of Electronic Publication: 2012 Feb 01.